| 产品名称: |
Anti-2019-nCoV S1 mAb (5D9) |
| 产品描述: |
Anti-2019-nCoV S1 mAb is a human monoclonal antibody human IgG1 and is produced by our Mammalian expression system. |
| 分子量: |
48.9&24.2 KDa |
| 表观分子量: |
58&28 KDa, reducing conditions |
| 产品纯度: |
Greater than 95% as determined by reducing SDS-PAGE. |
| 生物活性: |
Immobilized Anti-2019-nCoV S1 mAb (5D9) (Cat#NC025) at 5μg/ml (100 μl/well)can bind 2019-nCoV S Protein RBD -His(Cat#DRA120). The ED50 of 2019-nCoV S Protein RBD (N501Y, C-6His)(Cat#DRA120) is 64.32 ng/ml. |
| 储存条件: |
Store at ≤-70°C, stable for 6 months after receipt.
Store at ≤-70°C, stable for 3 months under sterile conditions after opening.
Please minimize freeze-thaw cycles. |
| 运输条件: |
The product is shipped on dry ice/polar packs.
Upon receipt, store it immediately at the temperature listed below. |
| 研究背景: |
Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biological processes that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |